Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Solid Tumors × Cetuximab × Clear all

Phase

Status

Recruiting 4 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Colorectal Neoplasms 135 Head and Neck Neoplasms 94 Squamous Cell Carcinoma of Head and Neck 89 Carcinoma, Non-Small-Cell Lung 57 Colonic Neoplasms 44 Rectal Neoplasms 38 Neoplasm Metastasis 32 Neoplasms 28 Pancreatic Neoplasms 24 Lung Neoplasms 18 Carcinoma, Squamous Cell 17 Stomach Neoplasms 15 Tongue Neoplasms 13 Esophageal Neoplasms 13 Salivary Gland Neoplasms 11 Recurrence 10 Breast Neoplasms 10 Laryngeal Neoplasms 9 Mouth Neoplasms 8 Esophageal Squamous Cell Carcinoma 8 Carcinoma 8 Adenocarcinoma Of Esophagus 8 Adenocarcinoma of Lung 7 Neoplasms, Squamous Cell 6 Hypopharyngeal Neoplasms 6 Carcinoma, Renal Cell 6 Parkinson Disease 4, Autosomal Dominant Lewy Body 5 Oropharyngeal Neoplasms 5 Nasopharyngeal Carcinoma 5 Carcinoma, Hepatocellular 5

Interventions

Gemcitabine 9 Paclitaxel 8 atezolizumab 7 Carboplatin 7 Sunitinib 5 navitoclax 4 Topotecan 4 Irinotecan 4 Docetaxel 4 Bevacizumab 4 pazopanib 3 liposomal doxorubicin 3 cobimetinib 3 Nivolumab 3 Erlotinib Hydrochloride 3 zolbetuximab 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 2 temsirolimus 2 selicrelumab 2 plocabulin 2 envafolimab 2 darinaparsin 2 brigimadlin 2 adavosertib 2 Tablets 2 Sorafenib 2 Rifampin 2 RG7388 2 Panitumumab 2 NVP-BKM120 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT01702129 2014-09-09

Anti-EGFR Immunoliposomes in Solid Tumors

University Hospital, Basel, Switzerland

Phase 1 Completed

Other solid neoplasm

Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡